Ching-Hua Su Selected Research

sacchachitin

1/2012	Wound-healing effect of micronized sacchachitin (mSC) nanogel on corneal epithelium.
2/2005	Development of fungal mycelia as a skin substitute: characterization of keratinocyte proliferation and matrix metalloproteinase expression during improvement in the wound-healing process.
7/2004	Effect of SACCHACHITIN on keratinocyte proliferation and the expressions of type I collagen and tissue-transglutaminase during skin wound healing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ching-Hua Su Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 12/2008
5	Wounds and Injuries (Trauma) 09/2021 - 07/2004
3	Inflammation (Inflammations) 01/2022 - 03/2010
3	Liver Neoplasms (Liver Cancer) 09/2017 - 07/2008
2	Hypertension (High Blood Pressure) 01/2022 - 07/2008
2	Invasive Candidiasis 04/2020 - 12/2017
2	Hepatocellular Carcinoma (Hepatoma) 09/2017 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 10/2011 - 12/2008
2	Prostatic Neoplasms (Prostate Cancer) 01/2007 - 01/2004
1	Obesity 01/2022
1	Disease Progression 03/2020
1	Aneuploidy (Aneuploid) 09/2014
1	Prolapse 12/2013
1	Burns 01/2012
1	Corneal Injuries 01/2012
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2011
1	Osteoporosis 10/2011
1	Asthma (Bronchial Asthma) 03/2010
1	Chronic Disease (Chronic Diseases) 03/2010
1	Carcinogenesis 12/2008
1	Diarrhea 07/2008
1	Insulin Resistance 07/2008
1	Edema (Dropsy) 08/2007
1	Transitional Cell Carcinoma 01/2007
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2006
1	Ulcer 02/2005
1	Cicatrix (Scar) 07/2004

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 04/2020 - 01/2004
3	Amphotericin B (Amphotericin)FDA LinkGeneric 03/2020 - 03/2013
3	sacchachitinIBA 01/2012 - 07/2004
2	Matrix Metalloproteinases (MMPs)IBA 09/2021 - 02/2005
2	Ethanol (Ethyl Alcohol)IBA 03/2020 - 03/2013
2	Fluconazole (Zonal)FDA LinkGeneric 12/2017 - 09/2014
2	Polysaccharides (Glycans)IBA 01/2015 - 03/2010
2	Therapeutic UsesIBA 03/2013 - 12/2008
2	Complex MixturesIBA 01/2007 - 01/2007
2	AndrogensIBA 01/2007 - 01/2004
1	Phosphopyruvate Hydratase (Enolase)IBA 04/2020
1	Ergosterol (Lumisterol)IBA 09/2017
1	Sorafenib (BAY 43-9006)FDA Link 09/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	TriterpenesIBA 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015
1	Drug CombinationsIBA 01/2015
1	DNA (Deoxyribonucleic Acid)IBA 09/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2013
1	Hematoxylin (Haematoxylon)IBA 12/2013
1	polyethylene glycol polyethyleneimine nanogelIBA 01/2012
1	VaccinesIBA 12/2011
1	AntigensIBA 12/2011
1	OvalbuminIBA 03/2010
1	AllergensIBA 03/2010
1	CytokinesIBA 03/2010
1	Trypan Blue FDA Link 12/2008
1	Cyclin AIBA 12/2008
1	Insulin (Novolin)FDA Link 07/2008
1	Blood Glucose (Blood Sugar)IBA 07/2008
1	PPAR gammaIBA 07/2008
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2008
1	Triglycerides (Triacylglycerol)IBA 07/2008
1	ChitosanIBA 03/2008
1	Polypropylenes (Polypropylene)IBA 03/2008
1	CollagenIBA 03/2008
1	SolutionsIBA 03/2008
1	acrylic acid (acrylate)IBA 03/2008
1	Methanol (Carbinol)IBA 08/2007
1	Collagen Type I (Type I Collagen)IBA 07/2004
1	Indicators and Reagents (Reagents)IBA 07/2004

Therapy/Procedure

3	Therapeutics 03/2020 - 01/2007
3	Drug Therapy (Chemotherapy) 03/2020 - 11/2006
2	Complementary Therapies (Alternative Medicine) 01/2022 - 10/2011
1	Blepharoplasty 12/2013
1	Transplantation 10/2011
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2008